Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea
Clinical trial NCT03380390 · COMPLETED
Trial details
- NCT number
- NCT03380390
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-04
- Primary completion
- 2018-06-15
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.